The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients

BACKGROUND: Hemodialysis patients are at high risk for severe COVID-19. SARS-CoV-2 vaccination related safety and immunogenicity data in these patients are rare. METHODS: In this observational study SARS-CoV-2-seronegative hemodialysis patients were vaccinated with two doses of the Pfizer/BioNTech m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Zitt, Emanuel, Davidovic, Tamara, Schimpf, Judith, Abbassi-Nik, Armin, Mutschlechner, Beatrix, Ulmer, Hanno, Benda, Magdalena A., Sprenger-Mähr, Hannelore, Winder, Thomas, Lhotta, Karl
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242233/
https://ncbi.nlm.nih.gov/pubmed/34220867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.704773
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi